PL EN


Preferences help
enabled [disable] Abstract
Number of results
2010 | 58 | 1 | 67-75
Article title

In vitro photodynamic therapy with chlorin e6 leads to apoptosis of human vascular smooth muscle cells

Content
Title variants
Languages of publication
EN
Abstracts
EN
Percutaneous coronary intervention has become the most common and widely implemented method of heart revascularization. However, the development of restenosis remains the major limitation of this method. Photodynamic therapy (PDT) recently emerged as a new and promising method for the prevention of arterial restenosis. Here the efficacy of chlorin e6 in PDT was investigated in vitro using human vascular smooth muscle cells (TG/HA-VSMCs) as one of the cell types crucial in the development of restenosis. PDT-induced cell death was studied on many levels, including annexin V staining, measurement of the generation reactive oxygen species (ROS) and caspase-3 activity, and assessment of changes in mitochondrial membrane potential and fragmentation of DNA. Photosensitization of TG/HA-VSMCs with a 170 M of chlorin e6 and subsequent illumination with the light of a 672-nm diode laser (2 J/cm2) resulted in the generation of ROS, a decrease in cell membrane polarization, caspase-3 activation, as well as DNA fragmentation. Interestingly, the latter two apoptotic events could not be observed in photosensitized and illuminated NIH3T3 fibroblasts, suggesting different outcomes of the model of PDT in various types of cells. The results obtained with human VSMCs show that chlorin e6 may be useful in the PDT of aerial restenosis, but its efficacy still needs to be established in an animal model.
References
Document Type
ARTICLE
Publication order reference
Wojciech?Kalas, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Weigla 12, Wroclaw, Poland
YADDA identifier
bwmeta1.element.element-from-psjc-eb17b077-9fd8-3b94-9f78-100580de5e16
Identifiers
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.